Structure Therapeutics Inc.
GPCR
$19.61
$0.241.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -136.85% | -79.88% | -48.88% | -42.39% | -11.83% |
| Total Depreciation and Amortization | 25.43% | 23.42% | 198.88% | 232.53% | 213.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 158.42% | 1,292.63% | 877.78% | -35.61% | 888.36% |
| Change in Net Operating Assets | 251.57% | 16.74% | -119.63% | 397.75% | -132.99% |
| Cash from Operations | -106.71% | -53.25% | -67.83% | 4.19% | -56.23% |
| Capital Expenditure | 45.67% | -93.83% | 98.62% | 16.46% | -123.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 124.09% | 2,073.86% | 118.51% | -708.61% | -197.85% |
| Cash from Investing | 123.93% | 2,300.07% | 118.39% | -727.45% | -197.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.90% | 27.81% | -99.80% | -16.07% | 287,772.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -23.74% |
| Cash from Financing | -99.90% | 15.24% | -99.78% | -260.04% | 173,400.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.80% | 45.60% | -103.31% | -2,185.58% | 430.37% |